Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.60
+0.21 (3.80%)
Aug 21, 2026, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 99.65 billion as of August 21, 2026. Its market cap has decreased by -25.31% in one year.
Market Cap
99.65B
Enterprise Value
103.42B
Revenue
38.91B
Ranking
n/a
PE Ratio
36.64
Stock Price
5.60
ChartMarket Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 99.65B, an increase of 30,098.41%. That is a compound annual growth rate of 24.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 99.65B | -9.80% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 199.36B |
| Innovent Biologics | 168.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 129.67B |
| Akeso | 83.82B |
| RemeGen | 71.41B |
| Biocytogen Pharmaceuticals (Beijing) | 62.12B |
| Genscript Biotech | 61.80B |
| 3SBio | 42.34B |